MLM
63
2
DRI
61
-2
EW
40
2
MU
43
-4
SLB
48
2
GOOG
83
4
COF
60
-4
TROW
48
-2
KMI
55
-4
GOOGL
67
3
V
66
-4
OXY
41
4
FLR
36
-3
GWW
46
2
XYL
43
-4
CA
40
4
DG
32
-2
EQT
19
-5
CRM
59
4
F
42
-4
MLM
63
2
DRI
61
-2
EW
40
2
MU
43
-4
SLB
48
2
GOOG
83
4
COF
60
-4
TROW
48
-2
KMI
55
-4
GOOGL
67
3
V
66
-4
OXY
41
4
FLR
36
-3
GWW
46
2
XYL
43
-4
CA
40
4
DG
32
-2
EQT
19
-5
CRM
59
4
F
42
-4
Financhill
Back

Canadian Pacific Kansas City Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
60

CP
Canadian Pacific Kansas City

Last Price:
78.71
Seasonality Move:
2.98%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
60
Canadian Pacific Kansas City (CP) is a Buy

Is Canadian Pacific Kansas City a Buy, Sell or Hold?

  • The current Canadian Pacific Kansas City [CP] share price is $78.67. The Score for CP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CP Stock Price Chart

What is Canadian Pacific Kansas City's stock price today?

  • The Canadian Pacific Kansas City share price today is $78.67
    The current trend is relatively stagnant and CP is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 49.55 Sell
Chaikin Money Flow: 687940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.7 - 80.34) Buy
Bollinger Bands (100): (79.49 - 87.79) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.43 Buy
20-day SMA: 77.75 Buy
50-day SMA: 80.56 Sell
200-day SMA: 79.25 Sell
8-day EMA: 77.88 Buy
20-day EMA: 78.27 Buy
50-day EMA: 80.2 Sell
200-day EMA: 80.41 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Canadian Pacific Kansas City Earnings Growth & CP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.02 per share, an increase this year of $0.33 per share, and an increase next year of $0.58 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Canadian Pacific Kansas City Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):